RBC Europe’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $8.83M | Sell |
168,345
-4,148
| -2% | -$217K | 0.42% | 35 |
|
|
2022
Q1 | $8.93M | Buy |
172,493
+244
| +0.1% | +$12.6K | 0.36% | 37 |
|
|
2021
Q4 | $10.2M | Sell |
172,249
-232,274
| -57% | -$13.7M | 0.45% | 35 |
|
|
2021
Q3 | $17.4M | Buy |
404,523
+8,484
| +2% | +$365K | 0.71% | 28 |
|
|
2021
Q2 | $15.5M | Buy |
396,039
+180,303
| +84% | +$7.06M | 0.7% | 28 |
|
|
2021
Q1 | $7.82M | Sell |
215,736
-5,101
| -2% | -$185K | 0.42% | 36 |
|
|
2020
Q4 | $8.13M | Sell |
220,837
-8,079
| -4% | -$297K | 0.47% | 36 |
|
|
2020
Q3 | $7.97M | Sell |
228,916
-16,145
| -7% | -$562K | 0.53% | 33 |
|
|
2020
Q2 | $7.6M | Sell |
245,061
-8,456
| -3% | -$262K | 0.59% | 30 |
|
|
2020
Q1 | $7.85M | Sell |
253,517
-15,328
| -6% | -$475K | 0.78% | 22 |
|
|
2019
Q4 | $9.99M | Sell |
268,845
-5,438
| -2% | -$202K | 0.88% | 22 |
|
|
2019
Q3 | $9.35M | Sell |
274,283
-9,061
| -3% | -$309K | 0.92% | 20 |
|
|
2019
Q2 | $11.6M | Sell |
283,344
-4,189
| -1% | -$172K | 1.16% | 17 |
|
|
2019
Q1 | $11.6M | Sell |
287,533
-16,631
| -5% | -$670K | 1.28% | 16 |
|
|
2018
Q4 | $12.6M | Sell |
304,164
-5,045
| -2% | -$209K | 1.64% | 11 |
|
|
2018
Q3 | $12.9M | Buy |
309,209
+11,540
| +4% | +$483K | 1.43% | 14 |
|
|
2018
Q2 | $10.2M | Sell |
297,669
-2,039
| -0.7% | -$70.2K | 1.2% | 19 |
|
|
2018
Q1 | $10.1M | Buy |
299,708
+1,459
| +0.5% | +$49.1K | 1.23% | 17 |
|
|
2017
Q4 | $10.2M | Buy |
298,249
+463
| +0.2% | +$15.9K | 1.26% | 19 |
|
|
2017
Q3 | $10.1M | Buy |
+297,786
| New | +$10.1M | 1.32% | 19 |
|